New N-RAP-binding Partners Alpha-actinin, Filamin and Krp1 Detected by Yeast Two-hybrid Screening: Implications for Myofibril Assembly
Overview
Affiliations
N-RAP, a muscle-specific protein concentrated at myotendinous junctions in skeletal muscle and intercalated disks in cardiac muscle, has been implicated in myofibril assembly. To discover more about the role of N-RAP in myofibril assembly, we used the yeast two-hybrid system to screen a mouse skeletal muscle cDNA library for proteins capable of binding N-RAP in a eukaryotic cell. From yeast two-hybrid experiments we were able to identify three new N-RAP binding partners: alpha-actinin, filamin-2, and Krp1 (also called sarcosin). In vitro binding assays were used to verify these interactions and to identify the N-RAP domains involved. Three regions of N-RAP were expressed as His-tagged recombinant proteins, including the nebulin-like super repeat region (N-RAP-SR), the N-terminal LIM domain (N-RAP-LIM), and the region of N-RAP in between the super repeat region and the LIM domain (N-RAP-IB). We detected significant alpha-actinin binding to N-RAP-IB and N-RAP-LIM, filamin binding to N-RAP-SR, and Krp1 binding to N-RAP-SR and N-RAP-IB. During myofibril assembly in cultured chick cardiomyocytes, N-RAP and filamin appear to co-localize with alpha-actinin in the earliest myofibril precursors found near the cell periphery, as well as in the nascent myofibrils that form as these structures fuse laterally. In contrast, Krp1 is not localized until late in the assembly process, when it appears at the periphery of myofibrils that appear to be fusing laterally. The results suggest that sequential recruitment of N-RAP binding partners may serve an important role during myofibril assembly.
Kokot T, Zimmermann J, Schwable A, Reimann L, Herr A, Hofflin N Sci Rep. 2024; 14(1):27348.
PMID: 39521905 PMC: 11550807. DOI: 10.1038/s41598-024-78953-8.
Zhang Z, Xu K, Ji L, Zhang H, Yin J, Zhou M Front Cardiovasc Med. 2023; 10:1097957.
PMID: 36815016 PMC: 9940605. DOI: 10.3389/fcvm.2023.1097957.
Understanding the molecular basis of cardiomyopathy.
Bang M, Bogomolovas J, Chen J Am J Physiol Heart Circ Physiol. 2021; 322(2):H181-H233.
PMID: 34797172 PMC: 8759964. DOI: 10.1152/ajpheart.00562.2021.
Filamin C in cardiomyopathy: from physiological roles to DNA variants.
Song S, Shi A, Lian H, Hu S, Nie Y Heart Fail Rev. 2021; 27(4):1373-1385.
PMID: 34535832 DOI: 10.1007/s10741-021-10172-z.
The p.Ala2430Val mutation in filamin C causes a "hypertrophic myofibrillar cardiomyopathy".
Schanzer A, Schumann E, Zengeler D, Gulatz L, Maroli G, Ahting U J Muscle Res Cell Motil. 2021; 42(2):381-397.
PMID: 33710525 DOI: 10.1007/s10974-021-09601-1.